Kristen Sanfilippo/X
Jun 22, 2025, 12:53
Kristen Sanfilippo: Time to Anticoagulants Therapy is a Modifiable Risk Factor for PE-associated Mortality
Kristen Sanfilippo, Hematologist in the Division of Hematology at Washington University School of Medicine, shared a post on X:
“Time to Anticoagulants therapy is a modifiable risk factor for PE-associated mortality.
- Big weekend for Kelsey Bria
- Finished Residency
- Started Fellowship as our newest ASH HFFTP
- First Oral “
More posts from ISTH 2025 on Hemostasis Today.
-
Jul 17, 2026, 10:12Julien Perrin: Presenting Thalassemia Coagulation Research at ISTH 2026
-
Jul 17, 2026, 10:08Cihan Ay: Thank you for making ISTH 2026 such a remarkable congress
-
Jul 17, 2026, 10:06Laura Cunliffe: That Is a Wrap for Meg and Me at ISTH 2026 in Paris
-
Jul 17, 2026, 10:03Roberta Gualtierotti: Updating on the Standardization of ultrasound definitions in hemophilic arthropathy at the ISTH 2026
-
Jul 17, 2026, 09:57Hrushikesh Vyas – A Wonderful Week Presenting Inherited Thrombocytopenia Research at ISTH 2026
-
Jul 17, 2026, 09:42Samin Mohsenian: Proud to Receive a Top Poster Award at ISTH 2026
-
Jul 17, 2026, 09:36Wolfgang Miesbach: A Landmark Case of Supratherapeutic FIX Following Gene Therapy Presented at ISTH 2026
-
Jul 17, 2026, 09:28Lisa Astorga: Leaving ISTH 2026 Inspired by the Global Thrombosis and Hemostasis Community
-
Jul 17, 2026, 09:23Maxime Dely: Honored to Reach My 6th Plasma Donation of 2026